-
Hanshi Pharmaceutical successfully signed a contract to build a new base for the international cell technology industry
Time of Update: 2023-01-06
On November 8, 2022, the Quanzhou Industry-University-Research Fund Matchmaking Conference, hosted by the Quanzhou Municipal People's Government and jointly organized by Quanzhou Science and Technolo
-
The domestic rare disease market space is large, and multinational pharmaceutical companies have increased their layout with new drugs
Time of Update: 2023-01-06
In addition, Sanofi brought a number of new drugs for rare diseases to the Expo, including the first exhibition of the world's first approved nanobody drug Cablivi, which is the first drug targeted for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP).
-
Pharmaceutical equipment companies are working hard to sprint to the fourth quarter!
Time of Update: 2023-01-06
【Pharmaceutical Network Industry News】For pharmaceutical equipment companies, the fourth quarter is a key period to complete the annual target tasks, and there is no room for any relaxation. Recently,
-
Pharmaceutical equipment companies are working hard to sprint to the fourth quarter!
Time of Update: 2023-01-06
【Pharmaceutical Network Industry News】For pharmaceutical equipment companies, the fourth quarter is a key period to complete the annual target tasks, and there is no room for any relaxation. Recently,
-
The mergers and acquisitions of listed companies are hot, and there are 3 pharmaceutical companies in 1 day!
Time of Update: 2023-01-06
On the same day, Tailong Pharmaceutical issued an announcement on the participation of the company's wholly-owned subsidiary in the establishment of pharmaceutical industry funds and related party transactions, and the company's wholly-owned subsidiary Tailong Health intends to invest 10 million yuan to establish a new wholly-owned subsidiary Hangzhou Tailong Jintang Enterprise Management Co.
-
Can I participate in "Beijing Universal Health Insurance" with medical insurance from other places? Here comes the Q&A
Time of Update: 2023-01-06
A: Yes. When enrolling, what does the prompt "Please confirm whether the insured is the following groups", [new citizens, public medical care, and other medical insurance conditions that can participate in Beijing Universal Health Insurance]?
-
Another pharmaceutical company is expected to reap good results in 2022!
Time of Update: 2023-01-06
The reason for the change in performance is that the sales revenue of the company's stapler products in overseas markets increased, and the revenue of the stapler parts business increased compared with the previous year, so that the company's operating income and net profit increased compared with the previous year 。 According to the company's 2022 third quarter report, the main revenue reached 318 million yuan, a year-on-year increase of 3.
-
The big health industry has ushered in a "golden period" of development, and pharmaceutical companies are accelerating their layout
Time of Update: 2023-01-06
js?cdnversion='+~(-new Date()/36e5)];Great health is a global health concept proposed in response to the development of the times, social needs and changes in the disease spectrum, the industry has a strong development momentum and huge market potential.
-
Another domestic anti-cancer new drug approved for marketing!
Time of Update: 2023-01-06
, Ltd. announced that the company's self-developed new anti-cancer class 1 drug linperlisib has been approved by China's National Medical Products Administration (NMPA) on November 9, targeting the treatment of relapsed/refractory (R/R) follicular lymphoma (FL) under the trade name Intaru.
-
Bristol-Myers Squibb Dr. Xuejun Cai: "Cosmic gravitational waves" allow patients to benefit from innovation
Time of Update: 2023-01-06
"He emphasized that paying more attention to the needs of Chinese patients is not only reflected in Bristol-Myers Squibb's high focus on the indications of its products in the areas of diseases with high incidence in China, but also in the establishment of mechanisms to ensure that China occupies a very important position in the global development strategy.
-
New drug launches, hand-in-hand cooperation to improve accessibility... Good news continues in the field of diabetes medications
Time of Update: 2023-01-06
It is reported that in the field of drug research and development, there has been good news in China recently, that is, on October 8, the State Medical Products Administration approved the marketing of Dougliptin tablets (trade name: Huatang Ning), a Class 1 innovative drug declared by Hua Medicine, which can be combined with diet control and exercise to improve blood sugar control in adult patients with type 2 diabetes.
-
The beautiful service experience brought by "smart medical insurance" is "accelerating its flight into people's homes"
Time of Update: 2023-01-06
fell illhospitalWhen the elderly Sun Qiangmin, a retired employee in Haidian District, Beijing: There are more than 600 pages of information, and there are dozens of pages of detailed lists of expenses alone.
-
Latest health insurance revenue and expenditure data: Spending on new crown vaccines has decreased significantly
Time of Update: 2023-01-06
Overall, the national basic medical insurance participation rate remained stable, the total income of the medical insurance fund increased by 5.
Overall, the national basic medical insurance participation rate remained stable, the total income of the medical insurance fund increased by 5.
-
AI pharmaceutical research and development is hot, and transaction cooperation has gradually become an industry trend
Time of Update: 2023-01-06
On October 11, Illumina announced a strategic research collaboration with AstraZeneca to accelerate drug target discovery by combining the strengths of both companies in artificial intelligence (AI)-based genome interpretation and genomic analysis technologies, as well as industry expertise.
-
AI pharmaceutical research and development is hot, and transaction cooperation has gradually become an industry trend
Time of Update: 2023-01-06
On October 11, Illumina announced a strategic research collaboration with AstraZeneca to accelerate drug target discovery by combining the strengths of both companies in artificial intelligence (AI)-based genome interpretation and genomic analysis technologies, as well as industry expertise.
-
Service Upgrade! Medical insurance online mobile payment allows patients to seek medical treatment and run less errands
Time of Update: 2023-01-06
In the past, when insured citizens came to the hospital for medical insurance settlement, they needed to swipe the medical insurance electronic voucher or social security card at the window or self-service machine to pay the fee.
-
Service Upgrade! Medical insurance online mobile payment allows patients to seek medical treatment and run less errands
Time of Update: 2023-01-06
In the past, when insured citizens came to the hospital for medical insurance settlement, they needed to swipe the medical insurance electronic voucher or social security card at the window or self-service machine to pay the fee.
-
The mergers and acquisitions of listed companies are hot, and there are 3 pharmaceutical companies in 1 day!
Time of Update: 2023-01-06
On the same day, Tailong Pharmaceutical issued an announcement on the participation of the company's wholly-owned subsidiary in the establishment of pharmaceutical industry funds and related party transactions, and the company's wholly-owned subsidiary Tailong Health intends to invest 10 million yuan to establish a new wholly-owned subsidiary Hangzhou Tailong Jintang Enterprise Management Co.
-
Recently, pharmaceutical companies have been keen to participate in funds and invest in biomedicine and other fields
Time of Update: 2023-01-06
【Pharmaceutical Network Industry News】On November 10, Youningwei announced that the company intends to participate in the Shanghai Leading Relay Private Equity Partnership (Limited Partnership) for 50 million yuan, which will mainly focus on digital economy, advanced manufacturing, medical and health, consumer services and other industries to carry out investment.
-
Recently, pharmaceutical companies have been keen to participate in funds and invest in biomedicine and other fields
Time of Update: 2023-01-06
【Pharmaceutical Network Industry News】On November 10, Youningwei announced that the company intends to participate in the Shanghai Leading Relay Private Equity Partnership (Limited Partnership) for 50 million yuan, which will mainly focus on digital economy, advanced manufacturing, medical and health, consumer services and other industries to carry out investment.
